Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
|Disease Areas||Investigator||Organization||Phase||Trial Status||Targeted Enrollment||Detail|
|Howard Foyt||ViaCyte, Inc.||Phase 1/2||Closed||19|
|William Sietsema||Caladrius Biosciences||Phase 2||Completed||113|
|Manasi Jaiman||ViaCyte, Inc.||Phase 1/2||Active, not recruiting||75|
|Peter Stock||University of California, San Francisco||Phase 1/2||Recruiting||8|